Status:
COMPLETED
ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture
Lead Sponsor:
Chen Xiaoping
Conditions:
Peritoneal Metastasis
Eligibility:
All Genders
18-90 years
Brief Summary
This study aimed to address the issue of peritoneal metastasis (PM) following the rupture of hepatocellular carcinoma (HCC) and its adverse impact on patient prognosis. Clinical data from 522 patients...
Eligibility Criteria
Inclusion
- (1) HCC confirmed by pathologists (2) two preoperative imaging findings suggestive of tumor rupture (3) R0 resection (4) first tumor detection -
Exclusion
- (1) previous antitumor therapy (2) combination of other types of tumors (3) incomplete clinical data
- \-
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
522 Patients enrolled
Trial Details
Trial ID
NCT06102278
Start Date
January 1 2020
End Date
April 1 2023
Last Update
October 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030